52 Week Highs
Back to dashboard| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| TechCreate Group Ltd. Class A Ordinary Shares | TCGL | 172.84 | 172.84 | 0 | +167.48 (3124.63%) |
| Quince Therapeutics, Inc. - Common Stock | QNCX | 31.73 | 31.73 | 0 | +30.05 (1788.69%) |
| Mega Fortune Company Limited - Ordinary Shares | MGRT | 118.00 | 116.50 | 7,171 | +111.69 (1770.05%) |
| The Bank of New York Mellon Corporation Common Stock | BNY | 153.41 | 152.79 | 2,970,395 | +143.30 (1417.41%) |
| TJGC Group Limited - Class A Ordinary Shares | TJGC | 31.89 | 31.89 | 0 | +29.20 (1087.58%) |
| Moderna, Inc. - Common Stock | MRNA | 223.37 | 231.35 | 8,085,639 | +198.60 (801.78%) |
| agilon health, inc. Common Stock | AGL | 115.66 | 110.30 | 152,539 | +101.26 (703.33%) |
| Adlai Nortye Group Ltd. - American Depositary Shares | ANL | 10.61 | 10.52 | 152,057 | +9.05 (580.13%) |
| Erasca, Inc. - Common Stock | ERAS | 15.66 | 15.78 | 8,533,491 | +13.08 (506.98%) |
| Kodiak Sciences Inc - Common Stock | KOD | 111.19 | 108.25 | 972,266 | +91.68 (469.91%) |
| Vince Holding Corp. - Common Stock | VNCE | 13.67 | 12.91 | 190,590 | +11.20 (453.44%) |
| SELLAS Life Sciences Group, Inc. - Common Stock | SLS | 7.860 | 8.030 | 11,201,598 | +6.43 (449.65%) |
| Forte Biosciences, Inc. - Common Stock | FBRX | 76.99 | 76.99 | 0 | +62.91 (446.80%) |
| Climb Bio, Inc. - Common Stock | CLYM | 10.36 | 10.87 | 667,836 | +8.46 (445.26%) |
| Space Exploration Technologies Corp. - Class A Common Stock | SPCX | 139.11 | 139.94 | 78,515,537 | +113.47 (442.47%) |
| CareDx, Inc. - Common Stock | CDNA | 77.88 | 79.81 | 716,983 | +61.94 (388.74%) |
| MindForge Inc. - Class A Ordinary Shares | MF | 19.50 | 18.90 | 37,998 | +15.28 (362.09%) |
| PACS Group, Inc. Common Stock | PACS | 48.32 | 48.00 | 464,466 | +37.74 (356.71%) |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares | GLMD | 4.630 | 4.630 | 0 | +3.59 (345.19%) |
| Spyre Therapeutics, Inc. - Common Stock | SYRE | 104.00 | 102.91 | 746,235 | +80.50 (342.55%) |
| Fossil Group | FOSL | 8.430 | 8.740 | 1,127,824 | +6.52 (342.52%) |
| Avita Medical, Inc. - Common Stock | RCEL | 15.63 | 16.20 | 497,278 | +11.88 (316.80%) |
| Twist Bioscience Corporation - Common Stock | TWST | 111.60 | 114.22 | 2,047,038 | +84.73 (315.33%) |
| Q32 Bio Inc. - Common Stock | QTTB | 8.710 | 8.820 | 243,851 | +6.55 (303.24%) |
| MaxLinear, Inc - Common Stock | MXL | 55.78 | 58.96 | 1,696,840 | +41.88 (301.29%) |
| AXT Inc - Common Stock | AXTI | 41.84 | 43.54 | 10,664,845 | +31.40 (300.77%) |
| AN2 Therapeutics, Inc. - Common Stock | ANTX | 4.550 | 4.440 | 205,686 | +3.41 (299.12%) |
| Oruka Therapeutics, Inc. - Common Stock | ORKA | 105.35 | 104.99 | 679,679 | +78.27 (289.03%) |
| Eton Pharmaceuticals, Inc. - Common Stock | ETON | 63.93 | 61.45 | 601,303 | +46.99 (277.39%) |
| 10x Genomics, Inc. - Common Stock | TXG | 58.19 | 59.10 | 2,125,517 | +42.30 (266.21%) |
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>